Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Feb 8th 2020, Silver Chartbook – The bigger picture

The bigger picture Silver prices are driven by several different factors, which are often opposing in effect. What is the bigger picture? There’s an inverse relationship between the strength of the US-Dollar and the price of silver. This is a c...
Korbinian Koller | February 10, 2020 |

Top Small Cap Stocks - January 2020

Small cap (or small capitalization) is a direct reference to a particular company’s market size. This generally refers to shares of companies where market capitalization (the number of shares outstanding when multiplied by the price per share), or the overall v...
Stockhouse Editorial | July 24, 2019 |

Allakos Shares Double on AK002 Phase 2 Results and Earnings

Allakos Inc. shares are soaring today as the company reported Q2/19 earnings and announced positive results from its phase 2 study for its AK002 inhibitor used in the treatment of eosinophil and mast cell related diseases. Clinical stage biotech company Allak...
Streetwise Reports | August 7, 2019 |

Silver is set to outperform gold based on gold/silver ratio, ...

Silver is set to outperform gold based on gold/silver ratio, silver mining companies present excellent entry points. Gold and silver boosted by first Fed rate cut since 2008 crisis The Federal Reserve cut interest rates on Wednesday (July 31, 2019) for the first tim...
John Lee, CFA | August 12, 2019 |

Fed’s Cut Puzzle and Gold

At the end of July, the Fed trimmed the federal funds rate . However, the dovish U-turn within the FOMC amid solid US economy remains a mystery. We invite you to read our today’s article about the Fed’s cut puzzle and its find out what do...
Arkadiusz Sieron | September 6, 2019 |

Energy Sector Reaches Key Low Point - Start Looking For The Next Move

The Energy Sector ETF has been on fire recently with big price trends. We called a bottom/buy trigger in ERY in early July that resulted in a nearly +20% rally. Then, on August 29 th , we called for ERY to rotate lower, targeting the $46 to $47 level – setting up another price...
Chris Vermeulen | September 12, 2019 |

Plus Therapeutics Shares Trade Higher on Q3 Earnings and Business Restructuring

Plus Therapeutics shares opened 25% higher today after the firm reported Q3/19 financial and business results. In the most recent quarter, the company completed the change of its name, relocated its headquarters to Austin, and raised $15 million for R&D and working capital. ...
Streetwise Reports | November 18, 2019 |

Emerging Technologies to Drive Silver Demand

The price of silver soared in May, jumping more than 19 percent on safe haven demand as well as increased expectations of a swift economic recovery, given its many industrial applications. Not only was this silver’s best month since 2011, but it also mar...
Frank Holmes | June 4, 2020 |

NIO, Rock Tech Lithium, Volkswagen: Forget hydrogen!

The pandemic shows it: humans are social creatures who long for their loved ones and want to experience something in good company. Mobility is the key to this. In the face of climate change and air pollution, electric cars are an obvious solution. But if you look at the stock ...
Nico Popp | February 18, 2021 |

Deciphera's Shares Open 115% Higher on Phase 3 Ripretinib Results

Deciphera Pharmaceuticals announced positive top-line results from the INVICTUS pivotal phase 3 clinical study of ripretinib in patients with advanced gastrointestinal stromal tumors. Early this morning, clinical-stage biopharmaceutical company Deciphera Pharmaceutic...
Streetwise Reports | August 14, 2019 |
1 2